|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Department of Medical Microbiology, University of Ulm, Ulm, Germany
A viral oncogene carrying well-defined
Kb/Db-restricted epitopes was expressed in a
heat shock protein (hsp)-associated or nonassociated form in the murine
tumor cells P815 and Meth-A. Wild-type SV40 large T-Ag (wtT-Ag) is
expressed without stable hsp association; mutant (cytoplasmic cT-Ag) or
chimeric (cT272-green fluorescent fusion protein) T-Ag is expressed in
stable association with the constitutively expressed, cytosolic hsp73
(hsc70) protein. In vitro, remnants from apoptotic wtT-Ag- or
cT-Ag-expressing tumor cells are taken up and processed by immature
dendritic cells (DC), and the Kb/Db-binding
epitopes T1, T2/3, and T4 of the T-Ag are cross-presented to CTL in a
TAP-independent way. DC pulsed with remnants of transfected, apoptotic
tumor cells cross-presented the three T-Ag epitopes more efficiently
when they processed ATP-sensitive hsp73/cT-Ag complexes than when they
processed hsp-nonassociated (native) T-Ag. In vivo, more
IFN-
-producing CD8+ T cells were elicited by a DNA
vaccine that encoded hsp73-binding mutant T-Ag than by a DNA vaccine
that encoded native, non-hsp-binding T-Ag. Three- to 5-fold higher
numbers of T-Ag (T1-, T2/3-, or T4-) specific,
Db/Kb-restricted IFN-
-producing
CD8+ T cells were primed during the growth of transfected
H-2d Meth-A/cT tumors than during the growth of transfected
Meth-A/T tumors in F1(b x d) hosts. Hence, the
association of an oncogene with constitutively expressed, cytosolic
hsp73 facilitates cross-priming in vitro and in vivo of CTL by DC that
process material from apoptotic cells.
This article has been cited by other articles:
![]() |
P. Riedl, A. Wieland, K. Lamberth, S. Buus, F. Lemonnier, K. Reifenberg, J. Reimann, and R. Schirmbeck Elimination of Immunodominant Epitopes from Multispecific DNA-Based Vaccines Allows Induction of CD8 T Cells That Have a Striking Antiviral Potential J. Immunol., July 1, 2009; 183(1): 370 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kettner, F. Kalthoff, P. Graf, E. Priller, F. Kricek, I. Lindley, and T. Schweighoffer EWI-2/CD316 Is an Inducible Receptor of HSPA8 on Human Dendritic Cells Mol. Cell. Biol., November 1, 2007; 27(21): 7718 - 7726. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Bramswig, R. Knittelfelder, S. Gruber, E. Untersmayr, A. B. Riemer, K. Szalai, R. Horvat, R. Kammerer, W. Zimmermann, C. C. Zielinski, et al. Immunization with Mimotopes Prevents Growth of Carcinoembryonic Antigen Positive Tumors in BALB/c Mice Clin. Cancer Res., November 1, 2007; 13(21): 6501 - 6508. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schirmbeck, P. Riedl, M. Kupferschmitt, U. Wegenka, H. Hauser, J. Rice, A. Kroger, and J. Reimann Priming Protective CD8 T Cell Immunity by DNA Vaccines Encoding Chimeric, Stress Protein-Capturing Tumor-Associated Antigen J. Immunol., August 1, 2006; 177(3): 1534 - 1542. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chen, J. Lu, L. Wang, and Y.-H. Gan Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling J. Leukoc. Biol., February 1, 2004; 75(2): 260 - 266. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Schirmbeck, N. Fissolo, P. Chaplin, and J. Reimann Enhanced Priming of Multispecific, Murine CD8+ T Cell Responses by DNA Vaccines Expressing Stress Protein-Binding Polytope Peptides J. Immunol., August 1, 2003; 171(3): 1240 - 1246. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Noessner, R. Gastpar, V. Milani, A. Brandl, P. J. S. Hutzler, M. C. Kuppner, M. Roos, E. Kremmer, A. Asea, S. K. Calderwood, et al. Tumor-Derived Heat Shock Protein 70 Peptide Complexes Are Cross-Presented by Human Dendritic Cells J. Immunol., November 15, 2002; 169(10): 5424 - 5432. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Riedl, S. El Kholy, J. Reimann, and R. Schirmbeck Priming Biologically Active Antibody Responses Against an Isolated, Conformational Viral Epitope by DNA Vaccination J. Immunol., August 1, 2002; 169(3): 1251 - 1260. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |